BGGS
OACC

Boussard & Gavaudan Gestion SAS’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Boussard & Gavaudan Gestion SAS’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.7M Buy
+720,000
New +$7.67M 0.39% 34

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Boussard & Gavaudan Gestion SAS's OACC Position: Q2 2026 in Review

Boussard & Gavaudan Gestion SAS opened a new position in Oaktree Acquisition Corp III Life Sciences (OACC) in Q2 2026: 720,000 shares worth $7.7M. The stake represents 0.39% of the portfolio and ranks #34 among its holdings.

50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Boussard & Gavaudan Gestion SAS held 720,000 shares of Oaktree Acquisition Corp III Life Sciences worth $7.7M as of Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences was a new Boussard & Gavaudan Gestion SAS position in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.39% of Boussard & Gavaudan Gestion SAS's portfolio in Q2 2026, its #34 holding.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Boussard & Gavaudan Gestion SAS's 13F filing for Q2 2026, filed 19 Aug 2026.